26.86 USD
▲+0.82+3.15%
盘后 26.70 -0.60%
2026-11-19
市值
$1.80B
市盈率
46.69
EPS
0.56
股息率
—
52 周区间
21.52 – 31.97
成交量
1.01M
Beta
1.30
目标价
43.29
52W 低 21.5252W 高 31.97
价格走势
公司简介
Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company’s platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead pr...